Positions

Principal Investigator On

  • Characterizing the Negative Signaling in Dendritic Cells and Macrophages to Attenuate Inflammation and Bone Destruction in Rheumatoid Arthritis  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2020 - 2024
  • Mechanistic Basis of the Role of Cbx3 in Negatively Regulating Osteoclast Differentiation through Epigenetic Modification  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2019 - 2024
  • Inhibiting Inflammation and Bone Erosion in Periodontal Disease by Targeting Cell Endogenous Negative Signaling  awarded by National Institute of Dental and Craniofacial Research/NIH/DHHS 2019 - 2024
  • Ga13 Signaling Attenuates Periodontal Inflammation and Alveolar Bone Loss in the Mouse Model of Age-Associated Periodontitis  awarded by National Institute of Dental and Craniofacial Research/NIH/DHHS 2018 - 2023
  • Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling  awarded by National Institute of Dental and Craniofacial Research/NIH/DHHS 2014 - 2019
  • Transcriptional Regulation of Osteoclast Lineage Commitment and Differentiation  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2018
  • Novel RNAi Inhibits Both Inflammation and Bone Resorption in Oral Diseases  awarded by National Institute of Dental and Craniofacial Research/NIH/DHHS 2011 - 2012
  • The Role of AML 1 in Osteoclastogenesis and Osteoclast Gene Expression  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2010 - 2012
  • Role of RGS10 in Osteoclast Differentiation  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2010 - 2011
  • Education And Training

  • Doctor of Philosophy in Molecular Genetics, Zhejiang University 1988
  • Full Name

  • Yi-Ping Li